AMSF.NASDAQAmerisafe INC

Form 4: AMERISAFE CFO Sells 1,235 Shares in Planned Transaction

Sentiment:

Insider Transaction Report


AMERISAFE's EVP-CFO, Anastasios Omiridis, sold 1,235 shares of common stock for $40.74 per share on November 7, 2025, under a Rule 10b5-1 plan.

Summary

  • Anastasios Omiridis, Executive Vice President and Chief Financial Officer of AMERISAFE INC (AMSF), reported a sale of company common stock.
  • The transaction involved the disposition of 1,235 shares of common stock.
  • The shares were sold at a price of $40.74 per share.
  • The transaction occurred on November 7, 2025.
  • Following this sale, Mr. Omiridis beneficially owns 3,786 shares of AMERISAFE common stock.
  • The sale was executed pursuant to a Rule 10b5-1(c) plan, indicating a pre-arranged trading plan.

Sentiment

Score: 5

Explanation: A neutral score. While an insider sale can sometimes be perceived negatively, the disclosure that it was executed under a Rule 10b5-1 plan suggests it was a pre-planned personal financial management decision rather than a reaction to new company-specific information, thus mitigating negative sentiment.

Negatives

  • An insider, the EVP-CFO, sold a portion of their holdings, which can sometimes be perceived negatively by the market, although mitigated by the 10b5-1 plan.

Future Outlook

NA

Industry Context

This is a routine insider transaction filing and does not provide specific industry context. Insider sales can occur for various personal financial planning reasons and are common across all industries.

Stakeholder Impact

  • Shareholders may note the reduction in direct ownership by a key executive, though the 10b5-1 plan mitigates concerns about its implications for company performance.

Key Dates

DateDescription
11/07/2025Date of common stock transaction (sale)
11/10/2025Date of filing of the Statement of Changes in Beneficial Ownership

Recommendation

hold

The filing reports a routine, pre-scheduled insider sale by the EVP-CFO under a Rule 10b5-1 plan. This type of transaction is generally not indicative of a change in the company's fundamental outlook or a lack of confidence from management. Therefore, it does not provide a basis for a change in investment recommendation, suggesting a 'hold' position is appropriate based solely on this filing.

Keywords

AMERISAFE, AMSF, Insider Trading, Form 4, Stock Sale, CFO, Anastasios Omiridis, 10b5-1 Plan, Equity Transaction

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.